Parkinson disease

R Balestrino, AHV Schapira - European journal of neurology, 2020 - Wiley Online Library
Parkinson disease (PD) is the most common neurodegenerative movement disorder. In
Europe, prevalence and incidence rates for PD are estimated at approximately 108–257/100 …

Rutin as a potent antioxidant: Implications for neurodegenerative disorders

AB Enogieru, W Haylett, DC Hiss… - Oxidative medicine …, 2018 - Wiley Online Library
A wide range of neurodegenerative diseases (NDs), including Alzheimer's disease,
Parkinson's disease, Huntington's disease, and prion diseases, share common mechanisms …

ESPEN guideline clinical nutrition in neurology

R Burgos, I Bretón, E Cereda, JC Desport, R Dziewas… - Clinical Nutrition, 2018 - Elsevier
Neurological diseases are frequently associated with swallowing disorders and malnutrition.
Moreover, patients with neurological diseases are at increased risk of micronutrient …

[HTML][HTML] Parkinson's disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis

G DeMaagd, A Philip - Pharmacy and therapeutics, 2015 - ncbi.nlm.nih.gov
Parkinson’s Disease and Its Management - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search …

Pharmacological treatment of Parkinson disease: a review

BS Connolly, AE Lang - Jama, 2014 - jamanetwork.com
Importance Parkinson disease is the second most common neurodegenerative disease
worldwide. Although no available therapies alter the underlying neurodegenerative process …

Parkinson's disease: A review

DM Radhakrishnan, V Goyal - Neurology India, 2018 - journals.lww.com
Parkinson's disease is a common movement disorder seen in neurological practice, but the
diagnosis and management is challenging. The diagnosis is clinical and sometimes difficult …

Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson's disease: a multi …

A Antonini, AJ Stoessl, LS Kleinman… - … medical research and …, 2018 - Taylor & Francis
Background: Lack of a global consensus on the definition of advanced Parkinson's disease
(APD) and considerations for timing of device-aided therapies may result in heterogeneity in …

Responsive cortical stimulation for the treatment of medically intractable partial epilepsy

MJ Morrell - Neurology, 2011 - AAN Enterprises
Objectives: This multicenter, double-blind, randomized controlled trial assessed the safety
and effectiveness of responsive cortical stimulation as an adjunctive therapy for partial onset …

Deep-brain stimulation for Parkinson's disease

MS Okun - New England Journal of Medicine, 2012 - Mass Medical Soc
Deep-Brain Stimulation for Parkinson's Disease | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …

Levodopa in Parkinson's disease: current status and future developments

N Tambasco, M Romoli… - Current …, 2018 - ingentaconnect.com
Background: Ever since the pioneering reports in the 60s, L-3, 4-Dioxyphenylalanine
(levodopa) has represented the gold standard for the treatment of Parkinson's Disease (PD) …